It is still 'nothing new' as for what the market is searching for and that is DATA. This is just another delivery system for CF33. Good, as it's more targeted to hard to reach tumours - a win for patients, but does that mean our 2 methods of administering via IV and direct injection were not working well enough or fast enough? I wonder why they wouldn't launch this in the beginning of trails and test 3 systems of delivery seeing which one works best?
Wouldn't be surprised if we finish in the red today.
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration, page-46
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |